Avidity Biosciences (NasdaqGM:RNA) Update / Briefing September 10, 2025 08:00 AM ET Company ParticipantsKat Lange - Chief Business OfficerSarah Boyce - President & CEOSteve Hughes - Chief Medical OfficerMichael Flanagan - Chief Scientific OfficerKat LangeGood morning, and thank you so much for joining us today. I'm Kat Lang, chief health officer at Avinity Biosciences. Today, we are excited to share the first functional data from the explorer 44 open label extension study of Delverter for boys and young men ...